Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome assembly chaperone 3 (PSMG3) is a chaperone protein that promotes the assembly of the 20S proteasome, a core component of the ubiquitin-proteasome system responsible for regulated protein degradation in cells. PSMG3 likely interacts with PSMG1-PSMG2 heterodimers to orchestrate the correct and efficient assembly of proteasome complexes. It plays crucial roles in protein homeostasis, cell cycle regulation, and metabolic pathways[1][4][8]. Recent studies show that PSMG3 is highly expressed in various cancers, where it may drive tumor cell proliferation, migration, and poor prognosis. Its function as a proteasome assembly factor implicates it in broad cellular processes and disease mechanisms, particularly in oncogenesis and protein metabolism[2][3]. There are no known drugs directly targeting PSMG3, and the safety and therapeutic challenges remain undetermined in current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome assembly chaperone 3 (PSMG3).